Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

172 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Eligibility Acute Myelogenous Leukemia NCT00510133

- 21/01/2016 - 1 formulario, 2 itemgroups, 10 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study of Active Immunotherapy With GRNVAC1 in Patients With Acute Myelogenous Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT00510133

Eligibility Acute Myelogenous Leukemia NCT00656448

- 21/01/2016 - 1 formulario, 2 itemgroups, 15 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS; ODM derived from: https://clinicaltrials.gov/show/NCT00656448

Eligibility Acute Myelogenous Leukemia NCT00475384

- 21/01/2016 - 1 formulario, 2 itemgroups, 23 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Haploidentical Transplantation in Patients With Acute Leukemia and Myelodysplasia; ODM derived from: https://clinicaltrials.gov/show/NCT00475384

Eligibility Acute Myelogenous Leukemia NCT00317642

- 20/01/2016 - 1 formulario, 2 itemgroups, 19 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I); ODM derived from: https://clinicaltrials.gov/show/NCT00317642

Eligibility Acute Myelogenous Leukemia NCT00270881

- 20/01/2016 - 1 formulario, 2 itemgroups, 12 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies; ODM derived from: https://clinicaltrials.gov/show/NCT00270881

Eligibility Acute Myelogenous Leukemia NCT00104468

- 20/01/2016 - 1 formulario, 2 itemgroups, 9 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT00104468

Eligibility Acute Myelogenous Leukemia NCT00074750

- 20/01/2016 - 1 formulario, 2 itemgroups, 17 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML); ODM derived from: https://clinicaltrials.gov/show/NCT00074750

Eligibility Acute Myelogenous Leukemia (AML) NCT00943553

- 20/01/2016 - 1 formulario, 2 itemgroups, 21 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Randomized Study of Epigenetic Priming Using Decitabine With Front Line Induction Chemotherapy Compared With Immediate Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT00943553

Eligibility Acute Myelogenous Leukemia NCT00038870

- 20/01/2016 - 1 formulario, 2 itemgroups, 11 items, 1 idioma
Itemgroups: Criteria, Exclusion Criteria
Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes; ODM derived from: https://clinicaltrials.gov/show/NCT00038870

Eligibility Acute Myelocytic Leukemia NCT00559091

- 20/01/2016 - 1 formulario, 2 itemgroups, 12 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00559091

Eligibility Acute Myeloblastic Leukemia NCT01966497

- 20/01/2016 - 1 formulario, 2 itemgroups, 13 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Observational Study of Patients Older Than 60 Years With Acute Myeloblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01966497

Eligibility Leukemia NCT00004263

- 12/01/2016 - 1 formulario, 2 itemgroups, 11 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT00004263

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial